Retraction to: Cell Death and Disease
https://doi.org/10.1038/cddis.2017.223 published online 25 May 2017
The Editors-in-Chief have retracted this article because the PTEN-shRNA panel in Fig. 6d appears to be the same as the Anti3142+PTEN-shRNA panel in Fig. 6h. The Editors-in-Chief therefore no longer have confidence in the integrity of the data in Fig. 6. All of the authors disagree with this retraction.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhao, L., Shan, Y., Liu, B. et al. Retraction Note: Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML. Cell Death Dis 11, 121 (2020). https://doi.org/10.1038/s41419-020-2319-1
Published:
DOI: https://doi.org/10.1038/s41419-020-2319-1